Feasibility Study: Comparison of Frontal Cortex Needle Core Versus Open Biopsy for Detection of Characteristic Proteinopathies of Neurodegenerative Diseases

Geidy E. Serrano, Anthony Intorcia, Jeremiah Carew, Glenn Chiarolanza, Jose A. Hidalgo, Lucia I. Sue, Brittany Dugger, Megan Saxon-Labelle, Jessica Filon, Alex Scroggins, Joel Pullen, Brandon E. Fornwalt, Sarah Scott, Marwan N. Sabbagh, Charles H. Adler, Haruhiko Akiyama, Thomas G. Beach

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

The clinical diagnosis and classification of neurodegenerative diseases based on clinical examination or available biomarkers are currently insufficiently accurate. Although histologic examination is considered the gold standard for diagnosis, brain biopsies have been avoided because of the high risk-benefit ratio. However, brain biopsies have previously been performed with a craniotomy and excision of approximately 1 cm3 of cerebral cortex tissue, and it is possible that needle core brain biopsies would have a lower morbidity and mortality risk. Here, we compared the ability of simulated needle core biopsy versus simulated open biopsy to detect the frontal cortex histopathology associated with common neurodegenerative diseases in the elderly using 144 autopsy-proven cases. Simulated needle core biopsy, as compared with simulated open biopsy, gave close to 90% sensitivity and specificity for identifying graded densities of β-amyloid and neuritic plaques, neurofibrillary tangles, phosphorylated α-synuclein, and phosphorylated TDP-43 pathology. This study shows that the presence and densities of the most common molecular pathologies may be histopathologically assessed in simulated frontal cortex needle biopsies, with accuracy very close to that obtained by open cortical biopsy. An accurate estimation of the morbidity and mortality risk associated with cortical needle core biopsy will require specifically designed clinical trials in appropriate subjects.

Original languageEnglish (US)
Pages (from-to)934-942
Number of pages9
JournalJournal of Neuropathology and Experimental Neurology
Volume74
Issue number9
DOIs
StatePublished - Jan 1 2015
Externally publishedYes

Fingerprint

Feasibility Studies
Frontal Lobe
Large-Core Needle Biopsy
Neurodegenerative Diseases
Needles
Biopsy
Amyloid Plaques
Brain
Synucleins
Morbidity
Neurofibrillary Tangles
Molecular Pathology
Mortality
Craniotomy
Needle Biopsy
Cerebral Cortex
Autopsy
Biomarkers
Odds Ratio
Clinical Trials

Keywords

  • Alzheimer disease
  • Amyloid plaque
  • Brain biopsy
  • Dementia with Lewy bodies
  • Frontotemporal dementia
  • Neuritic plaque
  • Neurofibrillary tangle
  • TDP-43

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Neurology
  • Clinical Neurology
  • Cellular and Molecular Neuroscience

Cite this

Feasibility Study : Comparison of Frontal Cortex Needle Core Versus Open Biopsy for Detection of Characteristic Proteinopathies of Neurodegenerative Diseases. / Serrano, Geidy E.; Intorcia, Anthony; Carew, Jeremiah; Chiarolanza, Glenn; Hidalgo, Jose A.; Sue, Lucia I.; Dugger, Brittany; Saxon-Labelle, Megan; Filon, Jessica; Scroggins, Alex; Pullen, Joel; Fornwalt, Brandon E.; Scott, Sarah; Sabbagh, Marwan N.; Adler, Charles H.; Akiyama, Haruhiko; Beach, Thomas G.

In: Journal of Neuropathology and Experimental Neurology, Vol. 74, No. 9, 01.01.2015, p. 934-942.

Research output: Contribution to journalArticle

Serrano, GE, Intorcia, A, Carew, J, Chiarolanza, G, Hidalgo, JA, Sue, LI, Dugger, B, Saxon-Labelle, M, Filon, J, Scroggins, A, Pullen, J, Fornwalt, BE, Scott, S, Sabbagh, MN, Adler, CH, Akiyama, H & Beach, TG 2015, 'Feasibility Study: Comparison of Frontal Cortex Needle Core Versus Open Biopsy for Detection of Characteristic Proteinopathies of Neurodegenerative Diseases', Journal of Neuropathology and Experimental Neurology, vol. 74, no. 9, pp. 934-942. https://doi.org/10.1097/NEN.0000000000000235
Serrano, Geidy E. ; Intorcia, Anthony ; Carew, Jeremiah ; Chiarolanza, Glenn ; Hidalgo, Jose A. ; Sue, Lucia I. ; Dugger, Brittany ; Saxon-Labelle, Megan ; Filon, Jessica ; Scroggins, Alex ; Pullen, Joel ; Fornwalt, Brandon E. ; Scott, Sarah ; Sabbagh, Marwan N. ; Adler, Charles H. ; Akiyama, Haruhiko ; Beach, Thomas G. / Feasibility Study : Comparison of Frontal Cortex Needle Core Versus Open Biopsy for Detection of Characteristic Proteinopathies of Neurodegenerative Diseases. In: Journal of Neuropathology and Experimental Neurology. 2015 ; Vol. 74, No. 9. pp. 934-942.
@article{a2f9a8abe84b40fab5261edafa7022a9,
title = "Feasibility Study: Comparison of Frontal Cortex Needle Core Versus Open Biopsy for Detection of Characteristic Proteinopathies of Neurodegenerative Diseases",
abstract = "The clinical diagnosis and classification of neurodegenerative diseases based on clinical examination or available biomarkers are currently insufficiently accurate. Although histologic examination is considered the gold standard for diagnosis, brain biopsies have been avoided because of the high risk-benefit ratio. However, brain biopsies have previously been performed with a craniotomy and excision of approximately 1 cm3 of cerebral cortex tissue, and it is possible that needle core brain biopsies would have a lower morbidity and mortality risk. Here, we compared the ability of simulated needle core biopsy versus simulated open biopsy to detect the frontal cortex histopathology associated with common neurodegenerative diseases in the elderly using 144 autopsy-proven cases. Simulated needle core biopsy, as compared with simulated open biopsy, gave close to 90{\%} sensitivity and specificity for identifying graded densities of β-amyloid and neuritic plaques, neurofibrillary tangles, phosphorylated α-synuclein, and phosphorylated TDP-43 pathology. This study shows that the presence and densities of the most common molecular pathologies may be histopathologically assessed in simulated frontal cortex needle biopsies, with accuracy very close to that obtained by open cortical biopsy. An accurate estimation of the morbidity and mortality risk associated with cortical needle core biopsy will require specifically designed clinical trials in appropriate subjects.",
keywords = "Alzheimer disease, Amyloid plaque, Brain biopsy, Dementia with Lewy bodies, Frontotemporal dementia, Neuritic plaque, Neurofibrillary tangle, TDP-43",
author = "Serrano, {Geidy E.} and Anthony Intorcia and Jeremiah Carew and Glenn Chiarolanza and Hidalgo, {Jose A.} and Sue, {Lucia I.} and Brittany Dugger and Megan Saxon-Labelle and Jessica Filon and Alex Scroggins and Joel Pullen and Fornwalt, {Brandon E.} and Sarah Scott and Sabbagh, {Marwan N.} and Adler, {Charles H.} and Haruhiko Akiyama and Beach, {Thomas G.}",
year = "2015",
month = "1",
day = "1",
doi = "10.1097/NEN.0000000000000235",
language = "English (US)",
volume = "74",
pages = "934--942",
journal = "American Journal of Psychotherapy",
issn = "0002-9564",
publisher = "Lippincott Williams and Wilkins",
number = "9",

}

TY - JOUR

T1 - Feasibility Study

T2 - Comparison of Frontal Cortex Needle Core Versus Open Biopsy for Detection of Characteristic Proteinopathies of Neurodegenerative Diseases

AU - Serrano, Geidy E.

AU - Intorcia, Anthony

AU - Carew, Jeremiah

AU - Chiarolanza, Glenn

AU - Hidalgo, Jose A.

AU - Sue, Lucia I.

AU - Dugger, Brittany

AU - Saxon-Labelle, Megan

AU - Filon, Jessica

AU - Scroggins, Alex

AU - Pullen, Joel

AU - Fornwalt, Brandon E.

AU - Scott, Sarah

AU - Sabbagh, Marwan N.

AU - Adler, Charles H.

AU - Akiyama, Haruhiko

AU - Beach, Thomas G.

PY - 2015/1/1

Y1 - 2015/1/1

N2 - The clinical diagnosis and classification of neurodegenerative diseases based on clinical examination or available biomarkers are currently insufficiently accurate. Although histologic examination is considered the gold standard for diagnosis, brain biopsies have been avoided because of the high risk-benefit ratio. However, brain biopsies have previously been performed with a craniotomy and excision of approximately 1 cm3 of cerebral cortex tissue, and it is possible that needle core brain biopsies would have a lower morbidity and mortality risk. Here, we compared the ability of simulated needle core biopsy versus simulated open biopsy to detect the frontal cortex histopathology associated with common neurodegenerative diseases in the elderly using 144 autopsy-proven cases. Simulated needle core biopsy, as compared with simulated open biopsy, gave close to 90% sensitivity and specificity for identifying graded densities of β-amyloid and neuritic plaques, neurofibrillary tangles, phosphorylated α-synuclein, and phosphorylated TDP-43 pathology. This study shows that the presence and densities of the most common molecular pathologies may be histopathologically assessed in simulated frontal cortex needle biopsies, with accuracy very close to that obtained by open cortical biopsy. An accurate estimation of the morbidity and mortality risk associated with cortical needle core biopsy will require specifically designed clinical trials in appropriate subjects.

AB - The clinical diagnosis and classification of neurodegenerative diseases based on clinical examination or available biomarkers are currently insufficiently accurate. Although histologic examination is considered the gold standard for diagnosis, brain biopsies have been avoided because of the high risk-benefit ratio. However, brain biopsies have previously been performed with a craniotomy and excision of approximately 1 cm3 of cerebral cortex tissue, and it is possible that needle core brain biopsies would have a lower morbidity and mortality risk. Here, we compared the ability of simulated needle core biopsy versus simulated open biopsy to detect the frontal cortex histopathology associated with common neurodegenerative diseases in the elderly using 144 autopsy-proven cases. Simulated needle core biopsy, as compared with simulated open biopsy, gave close to 90% sensitivity and specificity for identifying graded densities of β-amyloid and neuritic plaques, neurofibrillary tangles, phosphorylated α-synuclein, and phosphorylated TDP-43 pathology. This study shows that the presence and densities of the most common molecular pathologies may be histopathologically assessed in simulated frontal cortex needle biopsies, with accuracy very close to that obtained by open cortical biopsy. An accurate estimation of the morbidity and mortality risk associated with cortical needle core biopsy will require specifically designed clinical trials in appropriate subjects.

KW - Alzheimer disease

KW - Amyloid plaque

KW - Brain biopsy

KW - Dementia with Lewy bodies

KW - Frontotemporal dementia

KW - Neuritic plaque

KW - Neurofibrillary tangle

KW - TDP-43

UR - http://www.scopus.com/inward/record.url?scp=84940556456&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84940556456&partnerID=8YFLogxK

U2 - 10.1097/NEN.0000000000000235

DO - 10.1097/NEN.0000000000000235

M3 - Article

C2 - 26230581

AN - SCOPUS:84940556456

VL - 74

SP - 934

EP - 942

JO - American Journal of Psychotherapy

JF - American Journal of Psychotherapy

SN - 0002-9564

IS - 9

ER -